RecallRadar

FDA Drug recall D-0306-2025

Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufa…

On 2025-04-09 the FDA classified a Class II recall of Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufa… by Biocon Pharma, citing failed dissolution specifications: lower than specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0306-2025
ClassificationClass II
Statusongoing
Initiated2025-03-17
Published2025-04-09
Last updated2026-09-13 11:52 UTC
CompanyBiocon Pharma
DistributionUS

Product

Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13

Reason

Failed dissolution specifications: lower than specifications

Identifiers

ndc70377-077-11
ndc70377-077-13
ndc70377-077-12
ndc70377-078-11
ndc70377-078-13
ndc70377-078-12
ndc70377-079-11
ndc70377-079-12
ndc70377-079-13
ndc70377-080-11
ndc70377-080-12
ndc70377-080-13
code_infoLot#: AVC24035, Exp 03/31/26

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0306-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.